Opa1 is Required for Proper Mitochondrial Metabolism in Early Development

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Mar 22

PMID 23516612

Citations 35

Authors

Jennifer J Rahn

Krista D Stackley

Sherine S L Chan

Affiliations

Soon will be listed here.

Abstract

Opa1 catalyzes fusion of inner mitochondrial membranes and formation of the cristae. OPA1 mutations in humans lead to autosomal dominant optic atrophy. OPA1 knockout mice lose viability around embryonic day 9 from unknown reasons, indicating that OPA1 is essential for embryonic development. Zebrafish are an attractive model for studying vertebrate development and have been used for many years to describe developmental events that are difficult or impractical to view in mammalian models. In this study, Opa1 was successfully depleted in zebrafish embryos using antisense morpholinos, which resulted in disrupted mitochondrial morphology. Phenotypically, these embryos exhibited abnormal blood circulation and heart defects, as well as small eyes and small pectoral fin buds. Additionally, startle response was reduced and locomotor activity was impaired. Furthermore, Opa1 depletion caused bioenergetic defects, without impairing mitochondrial efficiency. In response to mitochondrial dysfunction, a transient upregulation of the master regulator of mitochondrial biogenesis, pgc1a, was observed. These results not only reveal a new Opa1-associated phenotype in a vertebrate model system, but also further elucidates the absolute requirement of Opa1 for successful vertebrate development.

Citing Articles

Derivation and Characterization of Isogenic Mutant and Control Human Pluripotent Stem Cell Lines.

Pohl K, Zhang X, Ji J, Stiles L, Sadun A, Yang X Cells. 2025; 14(2).

PMID: 39851566 PMC: 11764107. DOI: 10.3390/cells14020137.

Mitochondrial Dynamics Drive Muscle Stem Cell Progression from Quiescence to Myogenic Differentiation.

Sommers O, Tomsine R, Khacho M Cells. 2024; 13(21.

PMID: 39513880 PMC: 11545319. DOI: 10.3390/cells13211773.

model to clarify the pathological significance of OPA1 in autosomal dominant optic atrophy.

Nitta Y, Osaka J, Maki R, Hakeda-Suzuki S, Suzuki E, Ueki S Elife. 2024; 12.

PMID: 39177028 PMC: 11343565. DOI: 10.7554/eLife.87880.

Opa1 processing is dispensable in mouse development but is protective in mitochondrial cardiomyopathy.

Ahola S, Pazurek L, Mayer F, Lampe P, Hermans S, Becker L Sci Adv. 2024; 10(31):eadp0443.

PMID: 39093974 PMC: 11296347. DOI: 10.1126/sciadv.adp0443.

Host Subcellular Organelles: Targets of Viral Manipulation.

Song M, Lee D, Lee C, Park S, Yang J Int J Mol Sci. 2024; 25(3).

PMID: 38338917 PMC: 10855258. DOI: 10.3390/ijms25031638.

References

LEHMAN J, Barger P, Kovacs A, Saffitz J, Medeiros D, Kelly D . Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest. 2000; 106(7):847-56. PMC: 517815. DOI: 10.1172/JCI10268. View

Ylikallio E, Page J, Xu X, Lampinen M, Bepler G, Ide T . Ribonucleotide reductase is not limiting for mitochondrial DNA copy number in mice. Nucleic Acids Res. 2010; 38(22):8208-18. PMC: 3001089. DOI: 10.1093/nar/gkq735. View

Gottlieb R, Gustafsson A . Mitochondrial turnover in the heart. Biochim Biophys Acta. 2010; 1813(7):1295-301. PMC: 3335292. DOI: 10.1016/j.bbamcr.2010.11.017. View

Chen H, McCaffery J, Chan D . Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell. 2007; 130(3):548-62. DOI: 10.1016/j.cell.2007.06.026. View

Kim J, Hwang J, Ko H, Seong M, Park B, Park S . Mitochondrial DNA content is decreased in autosomal dominant optic atrophy. Neurology. 2005; 64(6):966-72. DOI: 10.1212/01.WNL.0000157282.76715.B1. View

Suen D, Norris K, Youle R . Mitochondrial dynamics and apoptosis. Genes Dev. 2008; 22(12):1577-90. PMC: 2732420. DOI: 10.1101/gad.1658508. View

Nunnari J, Suomalainen A . Mitochondria: in sickness and in health. Cell. 2012; 148(6):1145-59. PMC: 5381524. DOI: 10.1016/j.cell.2012.02.035. View

Stackley K, Beeson C, Rahn J, Chan S . Bioenergetic profiling of zebrafish embryonic development. PLoS One. 2011; 6(9):e25652. PMC: 3183059. DOI: 10.1371/journal.pone.0025652. View

Hunter S, Jung D, Di Giulio R, Meyer J . The QPCR assay for analysis of mitochondrial DNA damage, repair, and relative copy number. Methods. 2010; 51(4):444-51. PMC: 2912960. DOI: 10.1016/j.ymeth.2010.01.033. View

10.

Davies V, Hollins A, Piechota M, Yip W, Davies J, White K . Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum Mol Genet. 2007; 16(11):1307-18. DOI: 10.1093/hmg/ddm079. View

11.

Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko G, Rudka T . OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006; 126(1):177-89. DOI: 10.1016/j.cell.2006.06.025. View

12.

Chen H, Chomyn A, Chan D . Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem. 2005; 280(28):26185-92. DOI: 10.1074/jbc.M503062200. View

13.

Kim M, Kang K, Kim C, Choi S . Real-time imaging of mitochondria in transgenic zebrafish expressing mitochondrially targeted GFP. Biotechniques. 2008; 45(3):331-4. DOI: 10.2144/000112909. View

14.

Veldman M, Lin S . Zebrafish as a developmental model organism for pediatric research. Pediatr Res. 2008; 64(5):470-6. DOI: 10.1203/PDR.0b013e318186e609. View

15.

Williams P, Morgan J, Votruba M . Mouse models of dominant optic atrophy: what do they tell us about the pathophysiology of visual loss?. Vision Res. 2010; 51(2):229-34. DOI: 10.1016/j.visres.2010.08.031. View

16.

Stainier D, Weinstein B, Detrich 3rd H, Zon L, Fishman M . Cloche, an early acting zebrafish gene, is required by both the endothelial and hematopoietic lineages. Development. 1995; 121(10):3141-50. DOI: 10.1242/dev.121.10.3141. View

17.

Alavi M, Fuhrmann N, Nguyen H, Yu-Wai-Man P, Heiduschka P, Chinnery P . Subtle neurological and metabolic abnormalities in an Opa1 mouse model of autosomal dominant optic atrophy. Exp Neurol. 2009; 220(2):404-9. DOI: 10.1016/j.expneurol.2009.09.026. View

18.

Exner N, Lutz A, Haass C, Winklhofer K . Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J. 2012; 31(14):3038-62. PMC: 3400019. DOI: 10.1038/emboj.2012.170. View

19.

Amati-Bonneau P, Valentino M, Reynier P, Gallardo M, Bornstein B, Boissiere A . OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain. 2007; 131(Pt 2):338-51. DOI: 10.1093/brain/awm298. View

20.

Dorn 2nd G, Clark C, Eschenbacher W, Kang M, Engelhard J, Warner S . MARF and Opa1 control mitochondrial and cardiac function in Drosophila. Circ Res. 2010; 108(1):12-7. PMC: 3337031. DOI: 10.1161/CIRCRESAHA.110.236745. View